Solifenacin (Bispec (5 mg)) is a urinary antispasmodic agent, prescribed for overactive bladder with or without incontinence.It works by blocking the action of certain chemicals in the body to help ...

With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record. Advisory Alert: It has come to our attention ...

Shares of pharma major Glenmark Pharma rose as much as 2.5 percent intraday Thursday as it has received tentative USFDA nod for Solifenacin Succinate tablets. "Glenmark Pharmaceuticals Inc., USA has ...

NEW DELHI: Glenmark Pharmaceuticals today said the US health regulator has granted tentative approval for tablets used for treatment of overactive bladder. The company has been granted tentative ...

NEW DELHI: Strides Pharma Science Friday said its step-down wholly-owned subsidiary has received approval from the US health regulator for Solifenacin Succinate tablets, used to treat overactive ...

Glenmark Pharmaceuticals received final approval from the United States (US) health regulator for Solifenacin Succinate tablets, used for treatment of overactive bladder, on Tuesday. The approved ...

In a separate filing, Strides said its step-down subsidiary Strides Pharma Global Pte Ltd Singapore has received nod from the USFDA for Solifenacin Succinate Tablets, 5 mg and 10 mg, which is the ...

Glenmark Pharmaceuticals today said the US health regulator has granted tentative approval for tablets used for treatment of overactive bladder. “We have been granted tentative approval by the United ...

New Delhi, Jun 22 (PTI) Glenmark Pharmaceuticals today said the US health regulator has granted tentative approval for tablets used for treatment of overactive bladder. The company has been granted ...